Central Pacific Bank - Trust Division’s Fidelity Disruptive Medicine ETF FMED Stock Holding History

Central Pacific Bank - Trust Division’s Portfolio FMED Stock Details FMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.77K	Hold	97	–	–	﹤0.01%	785
2026 Q1	$2.38K	Hold	97	–	–	﹤0.01%	787
2025 Q4	$2.62K	Hold	97	–	–	﹤0.01%	762
2025 Q3	$2.42K	Hold	97	–	–	﹤0.01%	768
2025 Q2	$2.32K	Hold	97	–	–	﹤0.01%	774
2025 Q1	$2.29K	Hold	97	–	–	﹤0.01%	778
2024 Q4	$2.39K	Hold	97	–	–	﹤0.01%	796
2024 Q3	$2.55K	Hold	97	–	–	﹤0.01%	778
2024 Q2	$2.33K	Hold	97	–	–	﹤0.01%	863
2024 Q1	$2.45K	Buy	+97	New	+$2.4K	﹤0.01%	858

Other funds holding FMED

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

GJIA

Glass Jacobson Investment Advisors Owings Mills, Maryland $321M AUM 20.69% 1-Year Est. Return

Central Pacific Bank - Trust Division's FMED Position: Q2 2026 in Review

Central Pacific Bank - Trust Division held its Fidelity Disruptive Medicine ETF (FMED) position steady in Q2 2026 at 97 shares worth $2.77K. The position accounts for ﹤0.01% of the portfolio, ranked #785.

Central Pacific Bank - Trust Division first reported a position in FMED in Q1 2024 and has held it in 10 quarters since. 4 funds tracked by Wall St. Rank hold FMED as of Q2 2026.

Central Pacific Bank - Trust Division held 97 shares of Fidelity Disruptive Medicine ETF worth $2.77K as of Q2 2026.
Central Pacific Bank - Trust Division left its Fidelity Disruptive Medicine ETF share count unchanged in Q2 2026.
Fidelity Disruptive Medicine ETF made up ﹤0.01% of Central Pacific Bank - Trust Division's portfolio in Q2 2026, its #785 holding.
Central Pacific Bank - Trust Division first reported a position in Fidelity Disruptive Medicine ETF in Q1 2024 and has held it in 10 quarters since.
4 funds tracked by Wall St. Rank held Fidelity Disruptive Medicine ETF as of Q2 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.